Prediction: Oracle Will Trade at This Price in 2027

2 days ago 3

Vandita Jadeja

Thu, June 18, 2026 astatine 11:36 AM CDT 4 min read

Quick Read

Oracle (ORCL) earns a BUY with a $250 terms target, arsenic its $638 cardinal backlog surged 363% twelvemonth implicit year.
CFO Safra Catz projects OCI gross increasing from $18 cardinal to $144 cardinal wrong 5 years connected surging AI infrastructure demand.
Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Oracle didn't marque the cut. Grab the names FREE today.

Oracle's (NYSE:ORCL) banal has been done the wringer implicit the past year, but the semipermanent AI infrastructure communicative has lone gotten much concrete. After the Q4 FY2026 net study connected June 10, 2026, shares really slipped, drafting attraction to the spread betwixt superior strength and the backlog underneath.

Our 24/7 Wall St. Price Target for Oracle

The banal trades astatine $188.33 arsenic of June 16, 2026. Our 24/7 Wall St. terms people for Oracle is $249.71 implicit the adjacent 12 months, implying 32.59% upside. Our proposal is buy, with assurance astatine 90%. The thesis rests connected a grounds backlog, accelerating unreality mix, and a guardant net ramp that the existent aggregate does not afloat reflect.

12-MONTH PRICE PREDICTION' with a acheronian bluish and greenish colour scheme. It is divided into respective sections. 'The Call' conception shows a existent terms of $188.33, an arrow pointing to a terms people of $249.71, indicating a '+32.59% UPSIDE' and a 'BUY' proposal with 90% confidence. 'How We Got There' lists Trailing P/E: $188.33, Forward P/E: $211.85, Analyst Consensus: $255.38 (WEIGHT 30%), and a Weighted Base (Pre-Adjustment): $220.20, accompanied by a horizontal barroom chart. 'Our Adjustments' details the calculation of the last terms people from a Weighted Base: $220.20 x 247FACTOR: 1.134, considering Analyst Consensus (+84% Bullish), Earnings Growth (+21.9% YoY), Sector Momentum (Technology), and Volatility (-Beta 1.66), arriving astatine a Final Price Target: $249.71. 'Bull Case: What Could Go Right' lists 3 affirmative factors: '$638 BILLION RPO BACKLOG (+363% YoY)', 'OCI REVENUE RAMP TO $144B FY31', and 'MULTICLOUD AI DATABASE GROWTH (+404% Q4)', with a 'BULL CASE TARGET: $356.54'. 'Bear Case: What Could Go Wrong' lists 3 antagonistic factors: 'NEGATIVE FREE CASH FLOW (-$23.7B FY26)', 'HIGH CAPEX ($55.7B TTM)', and 'AI CUSTOMER CONCENTRATION RISK', with a 'BEAR CASE TARGET: $211.13'. 'The Bottom Line' reiterates the Recommendation: BUY and Price Target: $249.71 (+32.59%).

A Choppy Year Despite a Blockbuster Backlog

Oracle has been 1 of the much volatile mega-caps successful the market. Shares are down 9.89% implicit the past twelvemonth and 8.49% implicit the past week, and they beryllium 26% beneath the 52-week precocious of $343.01.

Q4 FY2026 gross came successful astatine $19.184 cardinal with non-GAAP EPS of $2.11. Cloud infrastructure gross grew 93% to $5.787 billion, and Remaining Performance Obligations exploded to $638 billion, up 363% twelvemonth implicit year. Free currency travel swung to antagonistic $23.686 cardinal arsenic capex deed $55.663 billion, which is what acrophobic investors.

Why Bulls See a Breakout Above $350

The bull lawsuit rests connected Oracle's RPO conversion. CFO Safra Catz has pointed to an OCI gross ramp from $18 cardinal successful FY2026 to $144 cardinal wrong 5 years. Management has confirmed an FY2027 gross people of $90 cardinal with non-GAAP EPS of $8.05.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Oracle didn't marque the cut. Grab the names FREE today.

Multicloud AI Database gross grew 404% successful Q4, and Oracle Health is expected to scope double-digit maturation connected the caller AI Cerner release. If the 247Factor compounds astatine the bull rate, our exemplary points to $356.54 wrong 12 months, an 89.32% full return.

What Could Go Wrong

The carnivore lawsuit starts with the equilibrium sheet. Total liabilities beryllium astatine $218.703 billion, and absorption plans to rise astir $40 cardinal successful FY2027 done indebtedness and equity. Software licence gross declined 6% successful Q4, and AI lawsuit attraction is simply a existent risk.

Read Entire Article